Picton Mahoney Asset Management’s Gilead Sciences GILD Stock Holding History

Picton Mahoney Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.93M	Buy	71,232 +4,179	+6%	+$585K	0.07%	243
2025 Q4	$8.23M	Buy	67,053 +19,427	+41%	+$2.36M	0.06%	243
2025 Q3	$5.29M	Buy	47,626 +47,612	+340,086%	+$5.41M	0.05%	272
2025 Q2	$2K	Hold	14	–	–	﹤0.01%	708
2025 Q1	$2K	Hold	14	–	–	﹤0.01%	684
2024 Q4	$1K	Hold	14	–	–	﹤0.01%	684
2024 Q3	$1K	Buy	+14	New	+$1.07K	﹤0.01%	677
2015 Q4	–	Sell	-2,320	Closed	-$228K	–	317
2015 Q3	$228K	Buy	2,320 +370	+19%	+$41.1K	0.01%	198
2015 Q2	$228K	Buy	+1,950	New	+$213K	0.01%	202
2015 Q1	–	Sell	-243,600	Closed	-$23M	–	310
2014 Q4	$23M	Buy	+243,600	New	+$25.2M	1.09%	26
2014 Q1	–	Sell	-697,100	Closed	-$52.4M	–	352
2013 Q4	$52.4M	Buy	697,100 +23,800	+4%	+$1.66M	3.05%	2
2013 Q3	$42.3M	Sell	673,300 -173,100	-20%	-$10.3M	2.8%	2
2013 Q2	$43.4M	Buy	+846,400	New	+$44.1M	3.21%	1

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Picton Mahoney Asset Management's GILD Position: Q1 2026 in Review

Picton Mahoney Asset Management increased its Gilead Sciences (GILD) stake by 6.2% in Q1 2026, buying an estimated $585K and bringing the position to 71,232 shares worth $9.93M. The position accounts for 0.07% of the portfolio, ranked #243.

Picton Mahoney Asset Management first reported a position in GILD in Q2 2013 and has held it in 13 quarters since. The position peaked at $52.4M in Q4 2013. 2,314 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Picton Mahoney Asset Management held 71,232 shares of Gilead Sciences worth $9.93M as of Q1 2026.
Picton Mahoney Asset Management bought 4,179 Gilead Sciences shares in Q1 2026, an estimated $585K.
Gilead Sciences made up 0.07% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #243 holding.
Picton Mahoney Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 13 quarters since.
Picton Mahoney Asset Management's Gilead Sciences position peaked at $52.4M in Q4 2013.
2,314 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.